MARKET

PLX

PLX

PROTALIX BIOTHER
AMEX

Real-time Quotes | Nasdaq Last Sale

0.2363
-0.0168
-6.64%
Closed 16:00 10/22 EDT
OPEN
0.2400
PREV CLOSE
0.2531
HIGH
0.2497
LOW
0.2003
VOLUME
1.94M
TURNOVER
--
52 WEEK HIGH
0.6000
52 WEEK LOW
0.1700
MARKET CAP
35.06M
P/E (TTM)
-1.3604
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PLX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

PLX News

  • Protalix: A Close Look At BRIDGE's "Positive"12-Month Interim Data
  • Seeking Alpha - Article.1d ago
  • Best And Worst Small-Cap Stocks Now
  • Seeking Alpha - Article.5d ago
  • Protalix up 18% premarket on longer-term PRX-102 data
  • seekingalpha.5d ago
  • Protalix BioTherapeutics Announces Positive 12-Month Interim Data From the BRIDGE Phase III Open Label Switch-over Study of Pegunigalsidase Alfa for the Treatment of Fabry Disease
  • PR Newswire.5d ago

More

Industry

Biotechnology & Medical Research
+0.44%
Pharmaceuticals & Medical Research
+0.60%

Hot Stocks

Name
Price
%Change

About PLX

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other Latin American countries and Elelyso in the rest of the territories) for the treatment of Gaucher disease that has been approved for marketing in the United States, Brazil, Israel and other markets. The Company's product pipeline includes PRX-102 for the treatment of Fabry disease; AIR DNase (PRX-110) for Cystic Fibrosis, and Oral Anti-TNF (OPRX-106) Anti Inflammatory. PRX-102 or alpha-GAL-A is an enzyme replacement therapy product for the treatment of Fabry disease. AIR DNase is a plant cell recombinant human Deoxyribonuclease 1. Oral Anti-TNF represents a mode of administering a recombinant anti-TNF protein.
More

Webull offers Protalix Biotherapeutics Inc (PLX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.